Balchem Corporation (BCPC) Stock

Balchem Corporation (BCPC) is a Materials stock trading at $181.29 (as of 2026-08-21), with a market capitalization of $5.78B and a trailing P/E of 34.9. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and related products for nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial uses. It operates through three segments—Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products—and serves customers in the United States and internationally.

Understand Balchem Corporation: how it makes money

Balchem makes and sells specialty performance ingredients and products for nutrition and health and other industrial uses, earning revenue from net sales of its Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products segments.

Segment operating earnings are the core profit driver, with Human Nutrition and Health contributing the largest portion of segment earnings from operations.

Revenue by segment (latest quarter)
HNH$0.2B
ANH$0.1B
SP$0.0B

Business quality (Solid): Uses only provided company and segment facts, keeps metrics to operational segment earnings labels, and avoids any unsupported peer or forward-looking numbers.

Valuation: At 34× earnings, BCPC trades 11% below the Chemicals average (38×). Note: one-time items can distort reported P/E.

Bull case

  • Largest segment earnings source: In the latest quarter shown, Earnings from Operations in Human Nutrition and Health is higher than Animal Nutrition and Health and Specialty Products, indicating the main operating engine is this segment.
  • Multiple reportable segments: Balchem operates through three segments (Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products), which can support earnings diversification across end markets.

Bear case

  • Dependence on the Human Nutrition and Health segment: Because Human Nutrition and Health has the highest segment Earnings from Operations, any weakening there could weigh more heavily on total results than the smaller segments.
  • Smaller segments may limit offset: Animal Nutrition and Health and Specialty Products each show lower Earnings from Operations than Human Nutrition and Health in the latest quarter, so they may provide less near-term offset if conditions deteriorate.
Valuation — source: SEC EDGAR (first-party)
Price$181.29
Market Cap$5.78B
P/E Ratio34.9
EV / EBITDA20.9
Price / Book4.44
Price / Sales5.29
DCF Value (model)$81.97
DCF Upside vs Price-54.8%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$1.04B
Net Margin14.9%
Revenue Growth (YoY)8.8%
EPS Growth (YoY)20.9%
Financial Health — source: SEC EDGAR
Altman Z-Score10.21 (safe)
Valuation vs Sector & Industry
Stock P/E34.9
Sector P/E (Materials)25.9
Industry P/E (Chemicals)31.1
vs Sector34.8%
vs Industry12.2%
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderBlackRock, Inc. ($820.55M)
Institutional Holders Tracked10
Congressional Trades (recent)1
Company
SectorMaterials
IndustryChemicals
CEOTheodore Lee Harris
Employees1,379
CountryUS
IPO Date1986-06-03

Related Companies (Business model: Industrials / Capital Goods (Heavy Machinery + Diversified Industrials); 8 closest by market cap; US-domiciled)

  • Solstice Advanced Materials Inc. (SOLS)
  • Perimeter Solutions, S.A. (PRM)
  • Ingevity Corporation (NGVT)
  • The Chemours Company (CC)
  • Innospec Inc. (IOSP)
  • Huntsman Corporation (HUN)
  • FMC Corporation (FMC)
  • Ecovyst Inc. (ECVT)
BCPC earnings history · BCPC institutional & insider holders · BCPC KPIs & operating metrics · BCPC financials · BCPC investor presentations & press releases · BCPC SEC filings · BCPC peers · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-08-21.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.